Evidence map›Paper›PMID 30643350›Full record

ArticleMissouri medicine

Ovarian Cancer Survival in Missouri, 1996-2014.

Yilin Yoshida, Chester L Schmaltz, Jeanette Jackson-Thompson, Eduardo J Simoes

Abstract read
PubMed Full text at PMC
In one paragraph

Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yilin YoshidaYilin Yoshida, PhD, MPH is in the University of Missouri School of Medicine, Department of Health Management and Informatics, and the Missouri Cancer Registry and Research Center.
Chester L SchmaltzChester L. Schmaltz, PhD is in the University of Missouri School of Medicine, Department of Health Management and Informatics, and the Missouri Cancer Registry and Research Center.
Jeanette Jackson-ThompsonJeanette Jackson-Thompson, PhD, MSPH is in the University of Missouri School of Medicine, Department of Health Management and Informatics, and the Missouri Cancer Registry and Research Center.
Eduardo J SimoesEduardo J. Simoes, MD, MSc, is in University of Missouri School of Medicine, Department of Health Management and Informatics, Columbia, Missouri.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated relative survival (RS) for ovarian cancer (OC) overall, by demographic and by clinicopathological characteristics in Missouri. Survival data from the Missouri Cancer Registry were obtained for cases diagnosed 1996-2014. An improved OC survival, especially in late stage, was observed in the study period. Our findings showed demographic, especially race-associated, and geographical variations of OC survival. OC survival also differed by first course treatment received and histology. These differences indicate disparities in OC care.

Indexed as

AdultAgedAge DistributionFemaleHumansMiddle AgedMissouriOvarian NeoplasmsRisk FactorsSurvival AnalysisYoung Adult

Identifiers

PMID30643350
PMCPMC6312176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.